ScholarIQanswers from OpenAlex & ORCID
Waun Ki Hong
ResearcherPublications, citations & collaboration network
Waun Ki Hong is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Waun Ki Hong have?
ScholarIQindexed works
Waun Ki Hong has 950 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Waun Ki Hong have?
ScholarIQcitation count
Waun Ki Hong has 51,685 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Waun Ki Hong?
ScholarIQh-index
Waun Ki Hong has an h-index of 118 in OpenAlex.
What is the i10-index of Waun Ki Hong?
ScholarIQi10-index
Waun Ki Hong has an i10-index of 455 in OpenAlex.
What is the ORCID of Waun Ki Hong?
ScholarIQorcid
The ORCID for Waun Ki Hong is on the source record.
What is the OpenAlex record for Waun Ki Hong?
ScholarIQopenalex
The OpenAlex for Waun Ki Hong is on the source record.
What are the most-cited papers on Waun Ki Hong?
ScholarIQmost cited works
An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance
Lauren A. Byers, Lixia Diao, Jing Wang, Pierre Saintigny, Luc Girard, Michael Peyton, Li Shen, You-Hong Fan, Uma Giri, Praveen K. Tumula, Monique B. Nilsson, Jayanthi Gudikote, Hai T. Tran, Robert J. Cardnell, David J. Bearss, Steven L. Warner, Jason M. Foulks, Steven B. Kanner, Varsha Gandhi, Nancy Krett, Steven T. Rosen, Edward S. Kim, Roy S. Herbst, George R. Blumenschein, J. Jack Lee, Scott M. Lippman, K. Kian Ang, Gordon B. Mills, Waun Ki Hong, John N. Weinstein, Ignacio I. Wistuba, Kevin R. Coombes, John D. Minna, John V. Heymach
Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing
Jianjun Zhang, Junya Fujimoto, Jianhua Zhang, David C. Wedge, Xingzhi Song, Jiexin Zhang, Sahil Seth, Chi‐Wan Chow, Yu Cao, Curtis Gumbs, Kathryn A. Gold, Neda Kalhor, Latasha Little, Harshad S. Mahadeshwar, César A. Moran, Alexei Protopopov, Huandong Sun, Jiabin Tang, Xifeng Wu, Yuanqing Ye, William N. William, J. Jack Lee, John V. Heymach, Waun Ki Hong, Stephen G. Swisher, Ignacio I. Wistuba, P. Andrew Futreal
Co-occurring Genomic Alterations Define Major Subsets of <i>KRAS</i> -Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities
Ferdinandos Skoulidis, Lauren A. Byers, Lixia Diao, Vassiliki A. Papadimitrakopoulou, Pan Tong, Julie Izzo, Carmen Behrens, Humam Kadara, Edwin R. Parra, Jaime Rodriguez Canales, Jianjun Zhang, Uma Giri, Jayanthi Gudikote, María Angélica Cortez, Chao Yang, You-Hong Fan, Michael Peyton, Luc Girard, Kevin R. Coombes, Carlo Toniatti, Timothy P. Heffernan, Murim Choi, Garrett M. Frampton, Vincent A. Miller, John N. Weinstein, Roy S. Herbst, Kwok‐Kin Wong, Jianhua Zhang, Padmanee Sharma, Gordon B. Mills, Waun Ki Hong, John D. Minna, James P. Allison, P. Andrew Futreal, Jing Wang, Ignacio I. Wistuba, John V. Heymach
The BATTLE Trial: Personalizing Therapy for Lung Cancer
Edward S. Kim, Roy S. Herbst, Ignacio I. Wistuba, J. Jack Lee, George R. Blumenschein, Anne S. Tsao, David J. Stewart, Marshall E. Hicks, Jeremy J. Erasmus, Sanjay Gupta, Christine Alden, Suyu Liu, Ximing Tang, Fadlo R. Khuri, Hai T. Tran, Bruce E. Johnson, John V. Heymach, Li Mao, Frank V. Fossella, Merrill S. Kies, Vassiliki A. Papadimitrakopoulou, Suzanne E. Davis, Scott M. Lippman, Waun Ki Hong
Effect of KRAS Oncogene Substitutions on Protein Behavior: Implications for Signaling and Clinical Outcome
Nathan T. Ihle, Lauren A. Byers, Edward S. Kim, Pierre Saintigny, J. Jack Lee, George R. Blumenschein, Anne S. Tsao, Suyu Liu, Jill E. Larsen, Jing Wang, Lixia Diao, Kevin R. Coombes, Lu Chen, Shuxing Zhang, Mena Abdelmelek, Ximing Tang, Vassiliki A. Papadimitrakopoulou, John D. Minna, Scott M. Lippman, Waun Ki Hong, Roy S. Herbst, Ignacio I. Wistuba, John V. Heymach, Garth Powis